CD109 mediates tumorigenicity and cancer aggressiveness via regulation of EGFR and STAT3 signalling in cervical squamous cell carcinoma
Open Access
- 8 June 2020
- journal article
- research article
- Published by Springer Science and Business Media LLC in British Journal of Cancer
- Vol. 123 (5), 833-843
- https://doi.org/10.1038/s41416-020-0922-7
Abstract
Background CD109 was involved in the tumorigenesis and progression of various cancers via TGF-β1 signalling and STAT3 activation. As CD109 is strongly expressed in cervical squamous cell carcinoma, this study was conducted to investigate its functional characteristics in cervical cancer. Methods CD109 expression was examined by immunohistochemistry (IHC) with cervical tissue microarray. The effects of CD109 expression were examined on migration, cell proliferation, spheroid formation and soft-agar colony-formation assay. Meanwhile, cervical cancer cell lines with high CD109 expression were chosen for the functional study using siRNA knockdown and CRISPR/Cas9 knockout. Results IHC demonstrated an upregulation of CD109 in the cell membrane of cervical squamous cell carcinoma. CD109( + ) cells isolated by flow-cytometric sorting displayed enhanced migration, cell proliferation, sphere-forming and anchorage-independent cell growth ability. In contrast, silencing of CD109 expression could reverse the in vitro and in vivo tumorigenic and aggressive properties. Furthermore, CD109 induced EGFR-mediated STAT3 phosphorylation known to be responsible for cell migration, proliferation and maintenance of CSC phenotype. Conclusion Abundant CD109( + ) populations in cervical cancer cells potentially contributed to carcinogenesis and aggressiveness, whereas silencing of CD109 expression could reverse those properties. CD109 mediates cervical tumorigenicity and aggressiveness via CD109/EGFR/STAT3 signalling.Keywords
Funding Information
- This work was supported by the Seed Funding Programme for Basic Research, The University of Hong Kong.
This publication has 52 references indexed in Scilit:
- Investigation of prognostic significance of CD109 expression in women with vulvar squamous cell carcinomaOncoTargets and Therapy, 2013
- Cancer-initiating cells derived from established cervical cell lines exhibit stem-cell markers and increased radioresistanceBMC Cancer, 2012
- The TGF-β co-receptor, CD109, promotes internalization and degradation of TGF-β receptorsBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 2011
- CD109 release from the cell surface in human keratinocytes regulates TGF-β receptor expression, TGF-β signalling and STAT3 activation: relevance to psoriasisExperimental Dermatology, 2011
- Processing of CD109 by furin and its role in the regulation of TGF-β signalingOncogene, 2010
- Up‐regulation of CD109 expression is associated with carcinogenesis of the squamous epithelium of the oral cavityCancer Science, 2008
- Establishment of a novel specific ELISA system for rat N- and C-ERC/mesothelin. Rat ERC/mesothelin in the body fluids of mice bearing mesotheliomaCancer Science, 2008
- CD109 expression in squamous cell carcinoma of the uterine cervixPathology International, 2005
- STAT proteins: From normal control of cellular events to tumorigenesisJournal of Cellular Physiology, 2003
- Cell surface antigen CD109 is a novel member of the α2 macroglobulin/C3, C4, C5 family of thioester-containing proteinsBlood, 2002